SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

English version Introducing SWFTCoin (SWFTC) $SWFTC: Powering SWFT Blockchain and AI Services (SWFTGPT)  SwftCoin ($SWFTC) is the native utility token driving SWFT Blockchain's AI-powered ecosystem, SWFTGPT, and the first ever AI token featured on Coinbase. SWFTGPT is also the first domain-specific LLM for crypto.  SwftCoin key features include: 50% Reduced Transaction Fees: Lower costs on all transactions. AI Service Payments: Use $SWFTC to access SWFTGPT. Tools include expert market analysis,  predictions, and intelligent trading solutions.  Membership Benefits: Unlock premium features and AI agent services within SWFTGPT. AI-Powered Swaps: Enable precise, fast cross-chain transactions and analytics. SWFT Blockchain combines AI innovation with blockchain infrastructure, simplifying crypto trading while enhancing functionality through $SWFTC.   Chinese version $SWFTC：驱动 SWFT Blockchain 和 AI 服务（SWFTGPT） SwftCoin ($SWFTC) 是 SWFT Blockchain 的原生实用代币，为其 AI 驱动的生态系统 SWFTGPT 提供支持，同时也是 Coinbase 上首个 AI 代币。SWFTGPT 也是首个专注于加密领域的特定领域大型语言模型 (LLM)。 SwftCoin 的主要功能包括： 1、50% 交易费减免：降低所有交易成本。 2、AI 服务支付：使用 $SWFTC 访问 SWFTGPT 工具，包括专家市场分析、预测以及智能交易解决方案。 3、会员权益：解锁 SWFTGPT 的高级功能和 AI 代理服务。 4、AI 驱动的闪兑：实现精准快速的跨链交易和数据分析。 SWFT Blockchain 将 AI 创新与区块链基础设施结合，通过 $SWFTC 简化加密交易，并提升其功能性。

SwftCoin

SwftCoin is trending as traders discuss its potential for another pump, citing its fully diluted status and history of rapid price movements. Some community members point to the project's underlying technology and cross-chain capabilities while others speculate on potential exchange listings. Overall, there's a debate between those anticipating quick gains and others focused on long-term fundamentals.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is trending as users discuss its potential as a superior blockchain, citing its scalability, lower transaction costs, enhanced security, and eco-friendly design compared to platforms like SOL, APT, MATIC, BNB, SUI, XRP and BTC; community members express strong optimism for its future, particularly as it relates to institutional adoption, real-world asset management and regulatory adherence.

WorldFinancial

WorldFinancial (WLFI) is trending amid community discussions around its potential and recent price movements, with some speculating about a possible pump and others pointing to its relationship with ALT5 Sigma and real-world asset tokenization as catalysts; traders are actively debating its future potential and speculating on upcoming news.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain and as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin ($XCN) is trending as the community debates its potential for growth and whether it's subject to pump and dump schemes. The recent delisting of Binance perpetual futures is seen by some as a positive catalyst, potentially removing negative pressure. Community members are actively discussing technical analysis, accumulation strategies, and the upcoming Goliath Mainnet launch.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi is trending amid discussions about potential acquisitions, partnerships, and promising pipeline developments. The community is speculating on possible buyout targets and the impact of positive trial results, as well as potential expansion in the global market. News about a potential consumer health unit sale may also be influencing the stock's movement.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is trending as community members discuss its potential to outperform Bitcoin, while some point to Grayscale's filing to convert its BCH trust into an ETF as a potential catalyst. Bullish sentiment is fueled by the coin's recent price strength and perceived accumulation, with some anticipating a significant breakout soon. The community is also debating its utility as a faster and cheaper alternative to Bitcoin for transactions.

Bitcoin on Base is your your second chance at Bitcoin.  Buy BTCB, Hold BTCB, and get airdropped cbBTC. Wrapped Coinbase Bitcoin will be dropped twice a year to wallets holding atleast 2,400 BTCT tokens.   Please update the description to the following:   Bitcoin on Base (BTCB) combines the scarcity of Bitcoin with the speed, security and scalability of Base. Your second chance at Bitcoin has arrived.

Bitcoin on Base

Bitcoin on Base ($BTCB) is surging, sparking excitement as a potential second chance at early Bitcoin-like gains within Coinbase's Base network. Community chatter highlights its increasing popularity and potential for significant growth, with some suggesting it could reach substantial market caps. Discussions also focus on its unique features like Bitcoin mining utility and airdrops to holders.

XDC Network is an enterprise-ready hybrid Blockchain technology company optimized for international trade and finance. The XDC Network is powered by the native coin called XDC. The XDC protocol is architected to support smart contracts, 2000TPS, 2seconds transaction time, KYC to Masternodes (Validator Nodes). The XDC Chain (XinFin Digital Contract) uses XinFin Delegated Proof of Stake (XDPoS), with the intending to create a ‘highly-scalable, secure, permission, and commercial grade’ blockchain network. XinFin mainnet token XDC and also creates an opportunity to utilize the XinFin’s real-world use-cases such as TradeFinex.org, helps small and medium businesses or institutions originate their own financial requirements in a digital, fully structured manner so that they can distribute it to the bank or non-bank funders themselves using a common distribution standard.

XinFin Network

XDC is trending as the community discusses potential exchange listings and strategic partnerships that could expand the network's role in trade finance. Recent clarifications addressing fund-freezing capabilities have boosted investor confidence. The ongoing DeFi Surge Program is also a key talking point, enhancing liquidity and expanding XDC's utility.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community discusses its ISO 20022 compliance and the potential launch of its Super App, anticipating a significant impact on the payments sector. Community members are drawing comparisons to other cryptocurrencies and highlighting Zebec's focus on real-world payment infrastructure, suggesting it's undervalued at its current price. The discussion includes its potential role in bridging DeFi with traditional finance.

Monad

Monad is trending due to its pre-sale launch on Coinbase, with the community actively discussing the high demand and potential allocation sizes. Despite concerns about the timing amid broader market conditions, many are optimistic about the project's potential, drawing comparisons to previous successful launches like Sui. Speculation is building around its future price and the impact of venture capital involvement.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$VKTX  that is exaggerated form non escalation dose with high rate of fatigue , alopecia , vomit and DC. On top of slow heart rate.   I detailed the data if you go to my previous posts. 
Wt loss in escalation dose was about 14% 

Alopecia is particularly concerning 10% even in $LLY slow escalation dose.   Will be big issue for women ?    Could screw up all $PFE Bourla team plan with Metsera combination and limit class use.   Lilly should show alopecia grading ( was not detailed in Lancet paper )

Stock Warrior

GTL91

Dogan

Your favorite Viking investor.

mike

nlrmandate

robert

Daniel Gorski

$VKTX New GLP-1 alternative, eloralintide, leads to 20% weight loss in trial https://share.google/ImAdKNFnIEkpEwe0B

Trial participants who used eloralintide, a new weight loss medication that, instead of focusing on the hormone GLP-1, targets a different hormone called amylin, lost as much as 20% weight.

New GLP-1 alternative, eloralintide, leads to 20% weight loss in trial

StockTwits For Android 

Viking Therapeutics Inc

RANDY

$VKTX $LLY $PFE 
Of course, a phase 2 study focuses on dosing levels in orser to determine what doses and potential titrations manximize efficacy and minimize AEs. That said, Viking will file an IND for their amylin formulary by EOY, putting them about two years behind Lilly&#39;s entrant. 

It almost looks like Viking is Lilly&#39;s Mini Me, gicen their GLP-1/GIP dual agonist and amylin formularies. Viking is also working on a calcitonin agonist that, with amylin, will yield another dual agonist, DACRA, that may be another game-changer. Eventually, all four might be balanced in a quad-agonist offering, though that&#39;s  pretty far in the future.

StockTwits for iOS

Lilly(Eli) & Co

Pfizer Inc

  that is exaggerated form non escalation dose with high rate of fatigue , alopecia , vomit and DC. On top of slow heart rate.   I detailed the data if you go to my previous posts. 
Wt loss in escalation dose was about 14% 

Alopecia is particularly concerning 10% even in 

 slow escalation dose.   Will be big issue for women ?    Could screw up all 

 Bourla team plan with Metsera combination and limit class use.   Lilly should show alopecia grading ( was not detailed in Lancet paper )

Biolover

@biolover 

Thanks for posting… I was just off reading about that “wonder drug” and needed a little bit of grounding.

 

Thanks for posting… I was just off reading about that “wonder drug” and needed a little bit of grounding.